Advanced search
Publication Cover
Expert Review of Obstetrics & Gynecology Volume 7, 2012 - Issue 5
Journal homepage
28
Views
15
CrossRef citations to date
0
Altmetric
Special Report

Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy

Uciane K Scarlett Tumor Microenvironment and Metastasis Program Leader, The Wistar Institute, 3601 Spruce St, Philadelphia, PA 19104, USA
&
Jose R Conejo-Garcia Tumor Microenvironment and Metastasis Program Leader, The Wistar Institute, 3601 Spruce St, Philadelphia, PA 19104, USA. [email protected]
Pages 413-419 | Published online: 10 Jan 2014

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Elizabeth Magnotti & Wayne A. Marasco. (2018) The latest animal models of ovarian cancer for novel drug discovery. Expert Opinion on Drug Discovery 13:3, pages 249-257.
Read now
Karolina Okła, Iwona Wertel, Grzegorz Polak, Justyna Surówka, Anna Wawruszak & Jan Kotarski. (2016) Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges. International Reviews of Immunology 35:5, pages 372-385.
Read now
Dallas B. Flies, Tomoe Higuchi, Jaryse C. Harris, Vibha Jha, Phyllis A. Gimotty & Sarah F. Adams. (2016) Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103+ dendritic cells in late-stage ovarian cancer. OncoImmunology 5:8.
Read now

Articles from other publishers (12)

Haigang Ding, Juan Zhang, Feng Zhang, Yan Xu, Yijun Yu, Wenqing Liang & Qingping Li. (2022) Role of Cancer-Associated fibroblast in the pathogenesis of ovarian Cancer: Focus on the latest therapeutic approaches. International Immunopharmacology 110, pages 109052.
Crossref
Naoyuki Iwahashi, Midori Ikezaki, Yoshihiro Komohara, Yukio Fujiwara, Tomoko Noguchi, Kaho Nishioka, Kazuko Sakai, Kazuto Nishio, Mitsuharu Ueda, Yoshito Ihara, Kenji Uchimura, Kazuhiko Ino & Kazuchika Nishitsuji. (2022) Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis. PNAS Nexus 1:3.
Crossref
Zhijian Luo, Yantao Luo, Xiaoling Liang, Qingyang Lyu, Fanliang Meng, Xuncai Chen, Yupeng Wang, Weiyi Fang, Aimin Li & Dongfang Zhou. (2022) Alantolactone-Loaded Pegylated Prodrug Nanocarriers for Synergistic Treatment of Cisplatin-Resistant Ovarian Cancer via Reactivating Mitochondrial Apoptotic Pathway. ACS Biomaterials Science & Engineering 8:6, pages 2526-2536.
Crossref
Kuan Hu, Lei Yao, Zhijie Xu, Yuanliang Yan & Juanni Li. (2022) Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer. Frontiers in Cell and Developmental Biology 10.
Crossref
Katarzyna M. Terlikowska, Bożena Dobrzycka & Sławomir J. Terlikowski. (2021) Chimeric Antigen Receptor Design and Efficacy in Ovarian Cancer Treatment. International Journal of Molecular Sciences 22:7, pages 3495.
Crossref
Yanfei Yang, Yang Yang, Jing Yang, Xia Zhao & Xiawei Wei. (2020) Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy. Frontiers in Cell and Developmental Biology 8.
Crossref
Qizhen Cao, Wanqin Wang, Min Zhou, Qian Huang, Xiaoxia Wen, Jun Zhao, Sixiang Shi, Ku Geng, Fenge Li, Hiroto Hatakeyama, Chunyu Xu, David Piwnica-Worms, Weiyi Peng, Dapeng Zhou, Anil K. Sood & Chun Li. (2020) Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition. Nanomedicine: Nanotechnology, Biology and Medicine 25, pages 102169.
Crossref
Irina V. Tiper, Sarah M. Temkin, Sarah Spiegel, Simeon E. Goldblum, Robert L. GiuntoliIIII, Mathias Oelke, Jonathan P. Schneck & Tonya J. Webb. (2016) VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells. Clinical Cancer Research 22:16, pages 4249-4258.
Crossref
Alexandre de la Fuente, Lorena Alonso-Alconada, Clotilde Costa, Juan Cueva, Tomas Garcia-Caballero, Rafael Lopez-Lopez & Miguel Abal. (2015) M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis. Journal of the National Cancer Institute 107:9, pages djv184.
Crossref
Sarah F Adams & Fabian Benencia. (2015) Immunotherapy for ovarian cancer: what are the targets of the future?. Future Oncology 11:9, pages 1293-1296.
Crossref
Stephanie Lheureux & Amit M Oza. (2015) Targeting the microenvironment in ovarian cancer. The Lancet Oncology 16:5, pages 485-486.
Crossref
Xiaoyun Yang, Fangrong Shen, Wei Hu, Robert L. Coleman & Anil K. Sood. (2015) New ways to successfully target tumor vasculature in ovarian cancer. Current Opinion in Obstetrics & Gynecology 27:1, pages 58-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.